Gene responsible for relapses in young leukemia patients
Wednesday, October 26, 2011 - 15:31
in Health & Medicine
One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia.